HIGHLIGHTS
- who: • stroke • thrombolytic et al. from the 5018, Paris, France have published the Article: Nanomedicine as strategy fight thrombotic diseases This review highlights the preclinical and clinical research based on the use of nanoand micro-carriers in drug delivery, in the Journal: (JOURNAL)
- future: Maybe the use of large and ultrastrong magnets would be a possibility to overcome this limitation in the near future. This opens new perspectives for clinical thrombolytic therapy with the aim to reduce the dose and therefore hemorrhagic side effects. Loading thrombolytic drugs into nanocarriers opens new perspectives for thrombotic diseases . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.